Vir Biotechnology (VIR) Non Operating Income (2018 - 2026)

Vir Biotechnology (VIR) has 9 years of Non Operating Income data on file, last reported at $6.8 million in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income fell 63.63% year-over-year to $6.8 million; the trailing twelve-month figure through Mar 2026 stood at $29.7 million (down 56.01% YoY), and the FY2025 full-year result was $41.6 million, down 35.13% from the prior year.
• Non Operating Income climbed to $6.8 million in Q1 2026, from $4.9 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $22.8 million in Q3 2022 to a low of -$91.9 million in Q1 2022.
• A 5-year average of $5.3 million and a median of $12.5 million in 2024 frame the typical range for Non Operating Income.
• Across the five-year window, Non Operating Income sank 1101.06% in 2022 and jumped 8140.98% in 2024, its largest moves.
• Tracing VIR's Non Operating Income over 5 years: stood at -$1.1 million in 2022, then soared by 1707.31% to $18.3 million in 2023, then plunged by 31.68% to $12.5 million in 2024, then tumbled by 61.03% to $4.9 million in 2025, then jumped by 39.17% to $6.8 million in 2026.
• Business Quant data shows VIR's Non Operating Income at $6.8 million in Q1 2026, $4.9 million in Q4 2025, and $10.5 million in Q3 2025.